Methods of treating underlying inflammation from COPD or asthma

US10537550B2 · kind B2 · utility

Assignee

• MEDA PHARMA GMBH & CO. KG · DE

Inventors

• Joachim Goede · Hanau, DE
• Joachim Maus · Mühlheim, DE
• Peter Jurgen Cnota · Bad Homburg vor der Höhe, DE
• Istvan Szelenyi · Arnstorf, DE

Key dates

• Filing date: Aug 11, 2008
• Grant date: Jan 21, 2020
• Expiry date: Aug 11, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive component or underlying inflammation like asthma and chronic obstructive pulmonary disease (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the NOVOLIZER®.